Streetbeat News

Stock Prices

BRO

Brown & Brown (NYSE:BRO) has seen a 3.26% increase in short interest since its last report, with 2.25 million shares sold short, representing 0.95% of its float. This indicates a bearish sentiment among investors, although it's below the peer group average of 3.03%. The article suggests that an increase in short interest doesn't necessarily predict a stock price fall.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 8:45 pm

CAH

Cardinal Health (NYSE:CAH) has seen a decrease in short interest, with 8.61 million shares sold short, representing 4.72% of its float. This is a 19.32% decrease from its last report, taking an average of 3.06 days for traders to cover short positions. Short interest is a key indicator of market sentiment, and a decrease suggests a more bullish outlook among investors. Cardinal Health's short interest is higher than its peer group average of 3.84%.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 8:45 pm

NFLX

TD Cowen analyst John Blackledge maintains a Buy rating on Netflix (NASDAQ:NFLX) and raises the price target from $600 to $725, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 8:44 pm

VINC

Vincerx Pharma's shares dropped following the presentation of preliminary Phase 1 data for VIP236 and updates on its pipeline progress at the AACR Annual Meeting 2024.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 8:42 pm

ELEV

Elevation Oncology, Inc. (NASDAQ:ELEV) announced preclinical proof-of-concept data for its HER3-ADC program at the AACR Annual Meeting 2024. The data demonstrates the program's potential in treating HER3-expressing cancers with a novel antibody-drug conjugate (ADC) that selectively targets HER3. The company plans to nominate a development candidate later in 2024, aiming to advance this therapy closer to clinical trials. The HER3-ADC program, which includes the molecule HER3-ADC1, showed promising results in vitro and in vivo, outperforming a benchmark HER3-ADC in cytotoxicity assays and inducing tumor regression in a pancreatic cancer model.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 8:36 pm

SKLZ

Skillz Inc. (NYSE:SKLZ) received a notice from the NYSE on April 2, 2024, for not complying with the timely filing criteria by failing to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The NYSE Notice does not immediately affect the listing of SKLZ's common stock but requires the company to file the Form 10-K within six months to regain compliance. The NYSE may grant an extension or commence delisting proceedings depending on circumstances.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 8:32 pm

INVH

Invitation Homes Inc. (NYSE:INVH) is set to acquire around 500 newly built homes for $140 million, expanding its footprint in Charlotte, Jacksonville, and Nashville. This move, facilitated through partnerships with three top-tier homebuilders, aims to address the housing supply shortage and is expected to offer favorable risk-adjusted returns to shareholders. The company has already received 648 new homes in 2023 and anticipates around 1,000 new home deliveries in 2024.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 8:32 pm

EVA

Enviva Inc. (NYSE:EVA) received a notice from the NYSE on April 2, 2024, for not complying with the filing requirements due to a delay in submitting its Annual Report on Form 10-K for the year ended December 31, 2023. The NYSE has given Enviva six months until October 1, 2024, to file the report and regain compliance. Failure to do so within this period could lead to an extension or potential delisting.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 8:31 pm

ADD

CRCT

CZOO

EZGO

FFIE

GLBE

GNLN

MAMO

MOND

PLBY

TRNR

UCAR

In Monday's after-market session, several consumer discretionary stocks showed notable movements. Greenlane Holdings (GNLN), Massimo (MAMO), EZGO Technologies (EZGO), U Power (UCAR), Faraday Future (FFIE), and Global E Online (GLBE) were among the gainers, with increases ranging from 3.07% to 7.6%. On the downside, Color Star Tech (ADD), Mondee Holdings (MOND), Cricut (CRCT), Cazoo Group (CZOO), Interactive Strength (TRNR), and PLBY Group (PLBY) experienced declines between 3.33% and 6.0%.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 8:31 pm

BSGM

MBRX

In Monday's after-market session, several healthcare stocks showed significant movement. Kineta, Moleculin Biotech, and Cue Health were among the top gainers, with Kineta leading at a 24.3% increase. Conversely, BioSig Technologies, Scinai Immunotherapeutics, and Processa Pharma were the top losers, with BioSig Technologies dropping by 16.9%. These movements reflect the volatile nature of healthcare stocks in the market.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 8:31 pm